Journal for ImmunoTherapy of Cancer (Nov 2023)

1157 GQ1007: the next generation HER2-targeting antibody immune agonist conjugate with robust efficacy and favorable safety profile

Chong Liu,
Gang Qin,
Paul Song,
Lily Shi,
Yajun Sun,
Beibei Fan,
Hanwen Xu

Affiliations

Chong Liu: GenQuantum Healthcare, Suzhou, Jiangsu, China
Gang Qin: GenQuantum Healthcare, Suzhou, Jiangsu, China
Paul Song: GenQuantum Healthcare, Suzhou, Jiangsu, China
Lily Shi: GenQuantum Healthcare, Suzhou, Jiangsu, China
Yajun Sun: GenQuantum Healthcare, Suzhou, Jiangsu, China
Beibei Fan: GenQuantum Healthcare, Suzhou, Jiangsu, China
Hanwen Xu: GenQuantum Healthcare, Suzhou, Jiangsu, China

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.1157
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal